Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Miaoyin Spring Pharmaceutical is a pharmaceutical manufacturing enterprise based in Haikou, Hainan Province, China. Founded in 1992, the company focuses on the production of Traditional Chinese Medicine (TCM) and chemical generic drugs across multiple therapeutic areas, including respiratory, anti-infective, and cardiovascular health. Its facilities are GMP-certified and capable of producing various formulations such as tablets, capsules, and granules. The company is well-known for its Miaoyin Spring brand in the domestic Chinese market. It operates as a private entity dedicated to providing affordable healthcare solutions through a diverse portfolio of over-the-counter and prescription medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Miaoyin Spring Pharmaceutical.